SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Rallis India zooms on getting nod to expand capacity of Pendimethalin Plant in Dahej

24 Jan 2024 Evaluate

Rallis India is currently trading at Rs. 260.05, up by 7.00 points or 2.77% from its previous closing of Rs. 253.05 on the BSE.

The scrip opened at Rs. 255.00 and has touched a high and low of Rs. 263.35 and Rs. 247.40 respectively. So far 120375 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 272.00 on 05-Jan-2024 and a 52 week low of Rs. 186.50 on 22-May-2023.

Last one week high and low of the scrip stood at Rs. 268.50 and Rs. 247.00 respectively. The current market cap of the company is Rs. 5069.80 crore.

The promoters holding in the company stood at 55.08%, while Institutions and Non-Institutions held 22.46% and 22.46% respectively.

Rallis India has received an approval for capacity addition of the existing Pendimethalin Plant at Dahej SEZ unit. The existing capacity of the plant is around 5000 MT/Annum and the company now proposed for capacity addition of around 2000 MT/Annum to meet sales demand for international as well as domestic market. 

The expansion is expected to be completed in a phased manner by FY25 and it will require investment of around Rs 15 crore which will be financed through internal accruals. The Board of Directors of the Company at its meeting held on January 23, 2024 has approved the proposal. 

Rallis India is engaged in the business of providing crop care solutions and agri services to the farming community.


Rallis India Share Price

268.80 5.35 (2.03%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
UPL 665.00
PI Industries 3144.45
Bayer CropScience 4900.45
Sharda Cropchem 1109.70
Sumitomo Chemical 441.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×